Reaction
Paternal Exposure During Pregnancy reporting signals
As of the last recalculation, Paternal Exposure During Pregnancy appears in 848 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is AGALSIDASE BETA (PRR 21.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Agalsidase Beta | 8 | 21.4 | 21.5 |
| Esketamine Hydrochloride | 10 | 13.9 | 13.9 |
| Glecaprevir And Pibrentasvir | 6 | 13.5 | 13.5 |
| Risankizumab-Rzaa | 42 | 13.2 | 13.2 |
| Guselkumab | 18 | 12.6 | 12.6 |
| Erlotinib | 4 | 10.2 | 10.2 |
| Hydrocodone Bitartrate And Acetaminophen | 20 | 8.9 | 8.9 |
| Avapritinib | 4 | 8.1 | 8.1 |
| Isotretinoin | 14 | 7.0 | 7.0 |
| Bimekizumab | 4 | 4.6 | 4.6 |
| Salicylic Acid | 4 | 1.9 | 1.9 |